3.18 USD
-0.22 (-6.47%)
Last: Jan 30, 2026, 08:00 PM
We assign a fundamental rating of 2 out of 10 to EVAX. EVAX was compared to 525 industry peers in the Biotechnology industry. EVAX may be in some trouble as it scores bad on both profitability and health. EVAX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- EVAX had negative earnings in the past year.
- In the past year EVAX has reported a negative cash flow from operations.
- In the past 5 years EVAX always reported negative net income.
- EVAX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- EVAX has a Return On Assets (-53.35%) which is in line with its industry peers.
- EVAX's Return On Equity of -192.35% is on the low side compared to the rest of the industry. EVAX is outperformed by 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.35% | ||
| ROE | -192.35% | ||
| ROIC | N/A |
ROA(3y)-120.5%
ROA(5y)-109.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EVAX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- EVAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- EVAX has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for EVAX has been reduced compared to 5 years ago.
- Compared to 1 year ago, EVAX has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -0.52, we must say that EVAX is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -0.52, EVAX is in line with its industry, outperforming 58.29% of the companies in the same industry.
- A Debt/Equity ratio of 1.73 is on the high side and indicates that EVAX has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.73, EVAX is doing worse than 77.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.52 |
ROIC/WACCN/A
WACC5.38%
2.3 Liquidity
- A Current Ratio of 3.42 indicates that EVAX has no problem at all paying its short term obligations.
- EVAX has a Current ratio (3.42) which is comparable to the rest of the industry.
- EVAX has a Quick Ratio of 3.42. This indicates that EVAX is financially healthy and has no problem in meeting its short term obligations.
- With a Quick ratio value of 3.42, EVAX perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 45.07% over the past year.
- The Revenue has grown by 132.20% in the past year. This is a very strong growth!
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
Revenue 1Y (TTM)132.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%148.33%
3.2 Future
- Based on estimates for the next years, EVAX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.
- Based on estimates for the next years, EVAX will show a very strong growth in Revenue. The Revenue will grow by 40.90% on average per year.
EPS Next Y85.61%
EPS Next 2Y32.17%
EPS Next 3Y25.84%
EPS Next 5Y15.29%
Revenue Next Year14.66%
Revenue Next 2Y-56.29%
Revenue Next 3Y-25.99%
Revenue Next 5Y40.9%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for EVAX. In the last year negative earnings were reported.
- Also next year EVAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- EVAX's earnings are expected to grow with 25.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.17%
EPS Next 3Y25.84%
5. Dividend
5.1 Amount
- EVAX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EVAXION A/S / EVAX FAQ
Can you provide the ChartMill fundamental rating for EVAXION A/S?
ChartMill assigns a fundamental rating of 2 / 10 to EVAX.
Can you provide the valuation status for EVAXION A/S?
ChartMill assigns a valuation rating of 1 / 10 to EVAXION A/S (EVAX). This can be considered as Overvalued.
How profitable is EVAXION A/S (EVAX) stock?
EVAXION A/S (EVAX) has a profitability rating of 0 / 10.
What is the expected EPS growth for EVAXION A/S (EVAX) stock?
The Earnings per Share (EPS) of EVAXION A/S (EVAX) is expected to grow by 85.61% in the next year.